Clinical Trial Update: A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers [Phase 2]

View source ↗

Summary

Phase II clinical study evaluating SSGJ-706 in combination therapy for advanced gastrointestinal cancers is not yet recruiting. The study includes gastric cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• SSGJ-706 (SSGJ-706)

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC) | Phase 2 | Status: NOT_YET_RECRUITING